159 related articles for article (PubMed ID: 35277389)
21. Inactivated SARS-CoV-2 vaccine in primary Sjögren's syndrome: humoral response, safety, and effects on disease activity.
Pasoto SG; Halpern ASR; Guedes LKN; Ribeiro ACM; Yuki ENF; Saad CGS; da Silva CAA; de Vinci Kanda Kupa L; Villamarín LEB; de Oliveira Martins VA; Martins CCMF; Deveza GBH; Leon EP; Bueno C; Pedrosa TN; Santos REB; Soares R; Aikawa NE; Bonfa E
Clin Rheumatol; 2022 Jul; 41(7):2079-2089. PubMed ID: 35306594
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.
Signorelli F; Balbi GGM; Aikawa NE; Silva CA; Kupa LVK; Medeiros-Ribeiro AC; Yuki EF; Pasoto SG; Saad CG; Borba EF; Seguro LPC; Pedrosa T; Oliveira VAA; Costa ALCS; Ribeiro CT; Santos REB; Andrade DCO; Bonfá E
Lupus; 2022 Jul; 31(8):974-984. PubMed ID: 35593174
[TBL] [Abstract][Full Text] [Related]
23. Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases.
Gualano B; Sieczkowska SM; Lemes ÍR; da Silva RP; Pinto AJ; Mazzolani BC; Smaira FI; Aikawa NE; Kupa LVK; Pasoto SG; Medeiros-Ribeiro AC; Saad CGS; Yuk EFN; Silva CA; Swinton P; Hallal PC; Roschel H; Bonfa E
J Phys Act Health; 2023 Apr; 20(4):311-316. PubMed ID: 36870351
[TBL] [Abstract][Full Text] [Related]
24. The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA).
Frodlund M; Nived P; Chatzidionysiou K; Södergren A; Klingberg E; Hansson M; Ohlsson S; Pin E; Bengtsson A; Klareskog L; Kapetanovic M
Microbiol Spectr; 2024 Apr; 12(4):e0298123. PubMed ID: 38441463
[TBL] [Abstract][Full Text] [Related]
25. Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort.
Zecca E; Rizzi M; Tonello S; Matino E; Costanzo M; Rizzi E; Casciaro GF; Manfredi GF; Acquaviva A; Gagliardi I; Calzaducca E; Mallela VR; D'Onghia D; Minisini R; Bellan M; Castello LM; Gavelli F; Avanzi GC; Patrucco F; Chiocchetti A; Pirisi M; Rigamonti C; Lilleri D; Sola D; Sainaghi PP
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016388
[TBL] [Abstract][Full Text] [Related]
26. Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients.
Gualano B; Saad CGS; Sieczkowska SM; Lemes ÍR; da Silva RP; Pinto AJ; Mazzolani BC; Smaira FI; Gil S; Oliveira-Junior G; Aikawa NE; Medeiros-Ribeiro AC; Silva CA; Yuki EFN; Pasoto SG; Pereira RMR; Shinjo SK; Andrade DCO; Sampaio-Barros PD; Roschel H; Bonfa E
J Appl Physiol (1985); 2022 Mar; 132(3):682-688. PubMed ID: 35142560
[TBL] [Abstract][Full Text] [Related]
27. Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study.
Netto LC; Ibrahim KY; Picone CM; Alves APPS; Aniceto EV; Santiago MR; Parmejani PSS; Aikawa NE; Medeiros-Ribeiro AC; Pasoto SG; Yuki EFN; Saad CGS; Pedrosa T; Lara AN; Ceneviva C; Bonfa E; Kallas EG; Avelino-Silva VI
Lancet HIV; 2022 May; 9(5):e323-e331. PubMed ID: 35338835
[TBL] [Abstract][Full Text] [Related]
28. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
29. Dynamics of SARS-CoV-2 IgG antibodies and neutralising antibodies in rheumatic and musculoskeletal diseases patients with COVID-19.
Wang Q; Wu Y; Wu L; Lu C; Ke Y; Wang Y; Gu L; Shen Y; Tan W
Clin Exp Rheumatol; 2024 May; 42(5):1035-1042. PubMed ID: 38372719
[TBL] [Abstract][Full Text] [Related]
30. COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases.
Yeo JG; Teh KL; Chia WN; Book YX; Hoh SF; Gao X; Das L; Zhang J; Sutamam N; Poh SL; Lim AJM; Tay SH; Yaung KN; Ong XM; Leong JY; Wang LF; Albani S; Arkachaisri T
Rheumatology (Oxford); 2023 Sep; 62(9):3101-3109. PubMed ID: 36661304
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of the mRNA-1273 and ChAdOx1 nCoV-19 vaccines in Asian patients with autoimmune rheumatic diseases under biologic and/or conventional immunosuppressant treatments.
Liao HT; Tung HY; Chou CT; Tsai HC; Yen YN; Tsai CY
Scand J Rheumatol; 2022 Nov; 51(6):500-505. PubMed ID: 35638589
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
34. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
[TBL] [Abstract][Full Text] [Related]
35. Single-cell RNA sequencing to decipher the immunogenicity of ChAdOx1 nCoV-19/AZD1222 and mRNA-1273 vaccines in patients with autoimmune rheumatic diseases.
Chen YJ; Cheng PL; Huang WN; Chen HH; Chen HW; Chen JP; Lin CT; Tang KT; Hung WT; Hsieh TY; Chen YH; Chen YM; Hsiao TH
Front Immunol; 2022; 13():920865. PubMed ID: 35979368
[TBL] [Abstract][Full Text] [Related]
36. Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases.
Sieiro Santos C; Calleja Antolin S; Moriano Morales C; Garcia Herrero J; Diez Alvarez E; Ramos Ortega F; Ruiz de Morales JG
RMD Open; 2022 Jan; 8(1):. PubMed ID: 34987093
[TBL] [Abstract][Full Text] [Related]
37. Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases.
Arumahandi de Silva AN; Frommert LM; Albach FN; Klotsche J; Scholz V; Jeworowski LM; Schwarz T; Ten Hagen A; Zernicke J; Corman VM; Drosten C; Burmester GR; Biesen R
Ann Rheum Dis; 2022 Jun; 81(6):881-888. PubMed ID: 35288376
[TBL] [Abstract][Full Text] [Related]
38. Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study.
Barin B; Kasap U; Selçuk F; Volkan E; Uluçkan Ö
Lancet Microbe; 2022 Apr; 3(4):e274-e283. PubMed ID: 35165669
[TBL] [Abstract][Full Text] [Related]
39. Fourth dose of BNT162b2 vaccine for patients with autoimmune rheumatic diseases in a nationwide setting.
Bieber A; Brikman S; Novack L; Abuhasira R; Fawaz A; Abu-Shakra M; Zeller L; Ling E; Mader R; Sagy I
Rheumatology (Oxford); 2023 Oct; 62(10):3332-3338. PubMed ID: 36762825
[TBL] [Abstract][Full Text] [Related]
40. BNT162b2 mRNA COVID-19 vaccine and booster in patients with autoimmune rheumatic diseases: a national cohort study.
Bieber A; Sagy I; Novack L; Brikman S; Abuhasira R; Ayalon S; Novofastovski I; Abu-Shakra M; Mader R
Ann Rheum Dis; 2022 Jul; 81(7):1028-1035. PubMed ID: 35418481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
